Member of Lyonbiopole
Cynbiose is a specialty nonclinical CRO offering research services with a core expertise and focus on the non-human primate (NHP) model.
Our non-GLP services ranges from:
- Exploratory PK, PD and early tox studies
- Efficacy models (off the shelf and on-demand) for Infectious & respiratory diseases (ABSL 2 to 3, incl SARS-CoV-2, RSV, hMPV), neurovascular disorders, inflammation and immune disorders, ...
We provide dedicated solutions for:
- Aerosoltherapies & inhaled products
- Gene therapies
- Infectious & respiratory diseases : full preclinical package (in vitro, ex vivo and in vivo)
Xpansion : new facility opening in 2023 with increased in vivo capacities for infectious & respiratory diseases (ABSL 2 to 3) and gene therapies (GMO class 2)
Cynbiome : 1st excellence research network on microbiota and infectious diseases
Strategic application domain: Human Medicine
Application market: Infectious Diseases, Neurology & Mental Health Disorders, Oncology
Type of activity: CRO - Tools - R&D platform, Medical device, Therapeutics, Pharma or Biotech
Technologies: Animal model & In vivo testing, in vitro & Ex Vivo model, Imaging
Created on oct. 25th, 2008 - 19 employees
Address
1, avenue Bourgelat 69280 Marcy l'Etoile
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.
